• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchKiromic Biopharma
    Picture of Kiromic Biopharma logo

    KRBPQ — Kiromic Biopharma News Story

    $0.000.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    • Market Cap
      $0.00m
    • Enterprise Value
      $12.52m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • KRBPQ Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    KRBPQ Dividends
    All News

    NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:29 AM

    Picture of Kiromic Biopharma logoKiromic Biopharma
    24/05/2021 15:29
    NASDAQ TRADE HALT  KRBP.O  VOLATILITY TRADING PAUSE AT 10:29 AM
    

    Recent news on Kiromic Biopharma

    See all news
    • Brief: Kiromic Biopharma Files For Offering Up To 1 Million Units

      19/02/2025 22:54
    • Brief: Kiromic Biopharma Applies To List Common Stock On The NYSE American Under Symbol 'KRBP'

      17/01/2025 22:36
    • Brief: Kiromic Biopharma Advances Deltacel-01 Into Expansion Phase Following Safety Monitoring Committee's Unanimous Recommendation

      19/09/2024 13:53
    • Brief: Kiromic Biopharma Reports Favorable Results At Six Weeks From Fourth Patient In Deltacel-01 Clinical Trial

      29/05/2024 13:10
    • Brief: Kiromic BioPharma Adds UPMC as Fourth Deltacel-01 Clinical Trial Site

      20/05/2024 13:59

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.